QA: Biospecifics Technologies CORP in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000875622_2014_Biospecifics_Technologies_CORP.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000875622, Biospecifics Technologies CORP

  xvar xval
0 AssetsCurrent 18,273,461
1 IntangibleAssetsNetIncludingGoodwill 215,999
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 4,762,784
4 LiabilitiesCurrent 781,545
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,038,363
9 ResearchAndDevelopmentExpense 1,484,416
10 remainder_Expenses 2,684,816
11 remainder_Revenues 14,467,240
12 remainder_NetIncome 26,202
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 23,252,244
1 Liabilities 781,545
2 Expenses 9,207,595
3 Revenues 14,467,240
4 StockholdersEquity 22,470,699
5 NetIncome 5,285,847
6 ComprehensiveNetIncome 5,285,847
7 BaseVar 23,867,413
8 EconomicCapitalRatiobeforeLimitedLiability 4.52
9 EconomicCapitalRatio 4.79

Edgar->Model Mapping

Feature Distribution

Change over Time